Fulcrum Therapeutics Inc (FULC)
3.03 -0.08 (-2.57%) 15:55 ET [NASDAQ]
3.02 x 220 3.03 x 120
Realtime by (Cboe BZX)
3.02 x 220 3.03 x 120
Realtime - - (-) -
for Wed, Mar 26th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,212 | 25,563 | 35,098 | 35,412 | 57,052 |
| Marketable Securities | 182,809 | 210,658 | 167,823 | 182,750 | 55,862 |
| Receivables | 2,096 | 537 | 229 | 3,637 | 2,531 |
| TOTAL | $249,923 | $242,199 | $207,519 | $225,998 | $119,510 |
| Non-Current Assets | |||||
| PPE Net | 3,900 | 5,216 | 6,906 | 7,368 | 8,397 |
| Other Non-Current Assets | 6,895 | 10,279 | 12,260 | 1,634 | 1,670 |
| TOTAL | $10,795 | $15,495 | $19,166 | $9,002 | $10,067 |
| Total Assets | $260,718 | $257,694 | $226,685 | $235,000 | $129,577 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,164 | 2,757 | 3,638 | 4,788 | 4,079 |
| Accrued Expenses | 7,694 | 8,726 | 9,551 | 9,231 | 7,267 |
| TOTAL | $11,044 | $13,675 | $16,725 | $19,199 | $26,725 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 934 | 5,180 | 15,379 |
| aiOther Non-Current Liabilities | 6,640 | 8,826 | 11,018 | 4,262 | 6,022 |
| TOTAL | $6,640 | $8,826 | $11,018 | $4,262 | $7,671 |
| Total Liabilities | $17,684 | $22,501 | $27,743 | $23,461 | $34,396 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,979 | 61,935 | 61,759 | 40,637 | 32,672 |
| Common Shares | 54 | 62 | 52 | 41 | 28 |
| Retained earnings | -519,398 | -509,673 | -412,338 | -302,467 | -221,620 |
| Other shareholders' equity | 130 | -136 | -797 | -397 | -2 |
| TOTAL | $243,034 | $235,193 | $198,942 | $211,539 | $95,181 |
| Total Liabilities And Equity | $260,718 | $257,694 | $226,685 | $235,000 | $129,577 |